Biolife Solutions (BLFS) Amortizatization of Intangibles (2014 - 2026)
Biolife Solutions (BLFS) posted quarterly Amortizatization of Intangibles of $122000.0 for Q1 2026, up 16.19% year-over-year from $105000.0 in Q1 2025, and down 39.3% quarter-over-quarter from $201000.0 in Q4 2025.
Biolife Solutions (BLFS) Amortizatization of Intangibles (2014 - 2026) Analysis & Trends
Biolife Solutions (BLFS) has reported Amortizatization of Intangibles for 9 consecutive years, with $122000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Amortizatization of Intangibles rose 16.19% year-over-year to $122000.0; the TTM figure through Mar 2026 stood at $753000.0 (up 89.67% YoY), while the FY2025 annual figure was $736000.0, up 55.27% from the prior year.
- Amortizatization of Intangibles fell to $122000.0 in Q1 2026 per BLFS's latest filing, from $201000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $447000.0 in Q4 2022 and bottomed at $67000.0 in Q4 2024.
- Historically, Amortizatization of Intangibles has averaged $217214.3 across 5 years, with a median of $200500.0 in 2025.
- Annual changes were most pronounced in 2024 — Amortizatization of Intangibles plunged 71.2% — and 2025, when it jumped 200.0%.
- Biolife Solutions' Amortizatization of Intangibles stood at $447000.0 in 2022, then sank by 52.35% to $213000.0 in 2023, then sank by 68.54% to $67000.0 in 2024, then surged by 200.0% to $201000.0 in 2025, then tumbled by 39.3% to $122000.0 in 2026.
- Business Quant data shows BLFS's Amortizatization of Intangibles at $122000.0 in Q1 2026, $201000.0 in Q4 2025, and $230000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 38.80 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | - |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 10.34 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 500,000.00 |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | - |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | - |
| 10 | Biolife Solutions | 1.82 Bn | 1.73 Bn | 18.29 Mn | 75,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 75,000.00 |
| Jun 30, 2026 | 75,000.00 |
| Mar 31, 2026 | 122,000.00 |
| Mar 31, 2026 | 122,000.00 |
| Dec 31, 2025 | 201,000.00 |
| Dec 31, 2025 | 201,000.00 |
| Sep 30, 2025 | 230,000.00 |
| Sep 30, 2025 | 230,000.00 |
| Jun 30, 2025 | 200,000.00 |
| Jun 30, 2025 | 200,000.00 |
| Mar 31, 2025 | 105,000.00 |
| Mar 31, 2025 | 105,000.00 |
| Dec 31, 2024 | 67,000.00 |
| Dec 31, 2024 | 67,000.00 |
| Sep 30, 2024 | 89,000.00 |
| Sep 30, 2024 | 89,000.00 |
| Jun 30, 2024 | 136,000.00 |
| Jun 30, 2024 | 136,000.00 |
| Mar 31, 2024 | 182,000.00 |
| Mar 31, 2024 | 182,000.00 |